| Amgen Switzerland AG - Nplate 125 mcg, Pulver zur Herstellung einer Injektionslösung |
| 69065 | | 01 | | Nplate 125 mcg | | Pulver zur Herstellung einer Injektionslösung | | B02BX04 | | Romiplostim | | 06.06.2023 | | |
|
| Composition |
| romiplostimum 125 µg, mannitolum, saccharum, histidinum, polysorbatum 20, acidum hydrochloridum dilutum pro vitro. |
| Packungsbestandteile |
| Dry substance | | | | | | | | Active Agent | Dose |
|---|
| Romiplostimum | 125 µg |
| | BAG: Active Agent | Dose |
|---|
| Romiplostimum | 125 mcg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum Dilutum | | Histidine | | Mannitol | | Polysorbatum 20 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 223.68 | 259.70 | A | SL | No |
|
